The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines the country’s current economic situation after posting the second-highest GDP growth among G20 countries in 2020, highlights the crucial role of the life sciences industry during the pandemic and the opportunities available for international investors in the sector. In addition, he explains the government’s objectives to improve the healthcare system and industry in the upcoming years, including a revamped focus on R&D, digital health and biotechnology.
Turkey has become a regional hub in terms of R&D, design, production, logistics and management for investors especially in the life sciences industry because of the reforms, incentives, strategic location, high-skilled workforce, and robust and resilient economic structure
